City
Epaper

Paytm buyback shows firm believes shares are below intrinsic value, just how Berkshire Hathaway did it in the past

By IANS | Updated: December 10, 2022 15:45 IST

New Delhi, Dec 10 Paytm, India's leading mobile payments and financial services company, has informed the exchanges about ...

Open in App

New Delhi, Dec 10 Paytm, India's leading mobile payments and financial services company, has informed the exchanges about its plans to buyback shares as its management believes that it will be beneficial for its shareholders.

The company said that its decision for the same comes from its strong financial position and liquidity. A board meeting will be held on December 13 for the approval of the company's first ever share buyback.

Paytm's announcement has been welcomed by investors and analysts as the company's stock surged sharply during Friday's trading session.

While the details of the buyback will be disclosed by the company after the board meeting, social media is already abuzz with speculations about Paytm's move, with some even comparing the company's proposed move to Warren Buffet's Berkshire Hathaway, a top US multinational conglomerate.

A Twitter user pointed out how Paytm's proposed buyback move is quite like how Berkshire Hathaway has done it in the past, at a point when management believes shares are under their intrinsic value and its cash reserves aren't greatly impacted. It may be noted that Berkshire Hathaway is an investor in Paytm.

The user also attached a Berkshire Hathaway release related to share buyback from 2018, which said: "Under the amendment adopted by the Board of Directors, share repurchases can be made at anytime that both Warren Buffett, Berkshire's Chairman and CEO, and Charlie Munger, a Berkshire Vice Chairman, believe that the repurchase price is below Berkshire's intrinsic value, conservatively determined."

Another reason behind the proposed buyback is Paytm's strong net cash, cash equivalent and investable balance of Rs 9,182 crore (as of September 2022).

Analysts at Dolat Capital, a brokerage firm, believe that buy back at the current valuation makes sense, given declining need for organic capital allocation and "very compelling valuation for the Paytm business".

"We view this move to be very positive and would enhance business confidence. Maintain Buy with TP of Rs 1,400," Dolat Capital analysts noted.

Paytm made the proposed share buyback announcement after achieving consistently strong growth for multiple quarters due to its strong business model and subsequently rising monetisation from businesses such as payments, devices and financial services.

This is reflected in the company's strong 76 per cent y-o-y revenue growth at Rs 1,914 crore and 224 per cent y-o-y surge in contribution profit at Rs 843 crore in Q2FY23.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Berkshire HathawayBerkshireWarren buffettCharlie mungerindiaNew DelhiThe new delhi municipal councilDelhi south-westBerkshire hathaway inc.Warren buffetIndiUk-indiaRepublic of indiaIndia india
Open in App

Related Stories

MumbaiViral Sighting of Tesla Cybertruck Near Mumbai Stirs EV Enthusiasm (Photos)

NationalPM Narendra Modi Discusses Tech and Innovation Collaboration With Elon Musk

NationalTahawwur Rana Extradition: Pakistan Distances Itself From 26/11 Accused After Arrival in India

NationalIndia Expands Rafale Power: Rs 64,000 Crore Deal Cleared for Navy Fighter Jets

NationalHeatwave in India: Maharashtra, Gujarat Experience Unbearable Night and Day Time Temperature, Bengaluru Likely to Witness Rain

Technology Realted Stories

TechnologyStudy links antibiotic exposure before age two to childhood obesity

TechnologyBoult Audio’s net profit declines by 37 pc in FY24, revenue up 41 pc

TechnologyDr Kasturirangan: A legacy spanning decades that left an indelible mark on space science, education in India

TechnologyStudy decodes how malaria can lead to childhood cancer

TechnologyISRO, SCTIMST sign MoU to collaborate on Space Medicine